Thank you to everyone who was able to join our AESGP webinar on Wednesday 17 September 2026. If you missed it, you can watch it here. Want to have a closer look at all the slides? Simply click here.
The European pharmaceutical landscape is shifting faster than most OTC communication strategies can keep up with. This session cuts through the noise: what the EU Pharma Reform really means for self-care communication, where the risks lie, and how OTC companies need to adapt.
What we covered.
The EU Pharma Reform is the most significant overhaul of pharmaceutical law in 20 years, and its implications for OTC go well beyond product classification. This webinar focuses on what it means for how you communicate.
What we discussed.
EU Pharma Reform: New rules. New risks. New opportunities. Discover how the EU Pharma Reform could reshape market access, Rx-to-OTC switches, portfolio strategy, and stakeholder communication.
5 hidden communication compliance risks you can't ignore: from cross-border compliance gaps and AI-generated content to consumer trust erosion.
How to adapt: what responsible, effective OTC communication looks like in this environment, and why aligning Public Affairs, Regulatory and Communication is no longer optional.
A big thank you to AESGP for the invite, Ogilvy HealthCare Brussels for the amazing collaboration, and to the many people who joined us today. Amazing to see such a strong turnout and engagement around the EU Pharma Reform and the future of self-care communication.
Let's continue the conversation. We hope you’ll take the time to watch—and be inspired by the people, ideas, and work shaping the future of OTC product communication in Europe.